Free Trial

Nutanix (NTNX) Financials

Nutanix logo
$53.64 -1.33 (-2.42%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$52.16 -1.49 (-2.77%)
As of 06/5/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Nutanix

Annual Income Statements for Nutanix

This table shows Nutanix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 7/31/2015 7/31/2016 7/31/2017 7/31/2018 7/31/2019 7/31/2020 7/31/2021 7/31/2022 7/31/2023 7/31/2024 7/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-126 -108 -380 -297 -621 -873 -1,036 -799 -255 -125 188
Consolidated Net Income / (Loss)
-126 -108 -380 -297 -621 -873 -1,036 -799 -255 -125 188
Net Income / (Loss) Continuing Operations
-126 -108 -380 -297 -621 -873 -1,036 -799 -255 -125 188
Total Pre-Tax Income
-125 -106 -375 -290 -613 -855 -1,017 -780 -234 -101 212
Total Operating Income
-119 -105 -348 -280 -598 -829 -662 -459 -207 7.56 173
Total Gross Profit
140 333 519 769 932 1,021 1,102 1,260 1,531 1,825 2,203
Total Revenue
241 503 846 1,155 1,236 1,308 1,394 1,581 1,863 2,149 2,538
Operating Revenue
241 503 846 1,155 1,236 1,308 1,394 1,581 1,863 2,149 2,538
Total Cost of Revenue
101 171 327 386 304 287 292 321 332 324 335
Operating Cost of Revenue
101 171 327 386 304 287 292 321 332 324 335
Total Operating Expenses
259 437 867 1,050 1,530 1,850 1,765 1,718 1,738 1,817 2,031
Selling, General & Admin Expense
24 34 77 86 120 136 154 166 232 201 237
Marketing Expense
162 287 501 650 910 1,160 1,053 979 925 977 1,056
Research & Development Expense
74 116 289 314 501 554 558 573 581 639 737
Total Other Income / (Expense), net
-5.82 -1.29 -26 -9.31 -15 -26 -355 -321 -26 -109 39
Other Income / (Expense), net
-5.82 -1.29 -26 -9.31 -15 -26 -355 -321 -26 -109 39
Income Tax Expense
1.54 2.32 4.85 7.45 8.12 18 18 19 21 23 23
Basic Earnings per Share
($3.11) ($2.46) ($2.96) ($1.81) ($3.43) ($4.48) ($5.02) ($3.62) ($1.09) ($0.51) $0.70
Weighted Average Basic Shares Outstanding
40.51M 43.97M 128.30M 164.09M 181.03M 194.72M 206.48M 220.53M 233.25M 244.74M 267.48M
Diluted Earnings per Share
($3.11) ($2.46) ($2.96) ($1.81) ($3.43) ($4.48) ($5.02) ($3.62) ($1.09) ($0.51) $0.65
Weighted Average Diluted Shares Outstanding
40.51M 43.97M 128.30M 164.09M 181.03M 194.72M 206.48M 220.53M 233.25M 244.74M 294.08M
Weighted Average Basic & Diluted Shares Outstanding
40.51M 43.97M 128.30M 164.09M 181.03M 194.72M 206.48M 227.03M 239.61M 265.21M 268.80M

Quarterly Income Statements for Nutanix

This table shows Nutanix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2025 1/31/2025 4/30/2025 7/31/2025 1/31/2026 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-13 -16 33 -16 -126 62 56 63 39 103 72
Consolidated Net Income / (Loss)
-13 -16 33 -16 -126 62 56 63 39 103 72
Net Income / (Loss) Continuing Operations
-13 -16 33 -16 -126 62 56 63 39 103 72
Total Pre-Tax Income
-7.09 -11 39 -11 -119 66 65 65 45 98 81
Total Operating Income
-11 -5.71 37 -12 -12 49 65 49 31 84 71
Total Gross Profit
414 429 484 445 467 583 569 556 569 632 611
Total Revenue
494 511 565 525 548 671 655 639 653 723 703
Operating Revenue
494 511 565 525 548 671 655 639 653 723 703
Total Cost of Revenue
80 82 82 80 81 87 85 83 84 91 92
Operating Cost of Revenue
80 82 82 80 81 87 85 83 84 91 92
Total Operating Expenses
425 435 447 457 479 534 504 507 538 547 540
Selling, General & Admin Expense
49 48 50 51 52 61 60 61 63 68 61
Marketing Expense
229 235 237 246 259 285 261 260 281 278 284
Research & Development Expense
146 152 160 159 167 187 183 186 194 202 196
Total Other Income / (Expense), net
4.26 -5.28 2.10 0.66 -106 16 -0.36 16 14 13 11
Other Income / (Expense), net
4.26 -5.28 2.10 0.66 -106 16 -0.36 16 14 13 11
Income Tax Expense
6.20 4.87 6.35 4.69 7.55 3.48 8.66 1.24 6.49 -5.52 9.23
Basic Earnings per Share
($0.04) ($0.07) $0.13 ($0.06) ($0.51) $0.23 $0.21 $0.24 $0.14 $0.38 $0.27
Weighted Average Basic Shares Outstanding
233.25M 241.49M 243.85M 245.77M 244.74M 269.87M 267.14M 267.57M 267.48M 268.28M 265.95M
Diluted Earnings per Share
($0.04) ($0.07) $0.12 ($0.06) ($0.50) $0.21 $0.19 $0.22 $0.14 $0.36 $0.25
Weighted Average Diluted Shares Outstanding
233.25M 241.49M 298.54K 245.77M 244.74M 296.52M 293.35M 296.80M 294.08M 291.91M 287.48M
Weighted Average Basic & Diluted Shares Outstanding
239.61M 242.69M 244.33M 246.64M 265.21M 270.40M 266.66M 268.08M 268.80M 265.21M 270.32M

Annual Cash Flow Statements for Nutanix

This table details how cash moves in and out of Nutanix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 7/31/2015 7/31/2016 7/31/2017 7/31/2018 7/31/2019 7/31/2020 7/31/2021 7/31/2022 7/31/2023 7/31/2024 7/31/2025
Net Change in Cash & Equivalents
10 31 40 168 92 -78 -33 117 110 140 114
Net Cash From Operating Activities
-26 3.64 15 93 42 -160 -100 68 272 673 821
Net Cash From Continuing Operating Activities
-26 3.64 15 93 42 -160 -100 68 272 673 821
Net Income / (Loss) Continuing Operations
-126 -108 -380 -297 -621 -873 -1,036 -799 -255 -125 188
Consolidated Net Income / (Loss)
-126 -108 -380 -297 -621 -873 -1,036 -799 -255 -125 188
Depreciation Expense
17 26 38 50 78 94 94 88 76 73 73
Amortization Expense
- 0.00 0.00 15 29 31 64 40 43 42 3.88
Non-Cash Adjustments To Reconcile Net Income
24 18 257 177 304 357 380 427 303 448 357
Changes in Operating Assets and Liabilities, net
60 67 99 148 252 231 398 311 105 235 199
Net Cash From Investing Activities
-107 -47 -176 -504 -17 25 -597 -54 -50 530 -952
Net Cash From Continuing Investing Activities
-107 -47 -176 -504 -17 25 -597 -54 -50 530 -952
Purchase of Property, Plant & Equipment
-23 -42 -50 -62 -118 -89 -59 -49 -65 -75 -71
Acquisitions
0.00 0.00 -0.18 -22 -19 - - 0.00 0.00 -4.50 0.00
Purchase of Investments
-116 -106 -243 -716 -468 -607 -1,393 -1,081 -955 -871 -1,360
Divestitures
- - - - - - 0.00 0.00 5.91 0.00 0.00
Sale and/or Maturity of Investments
33 102 117 297 589 721 854 1,076 965 1,481 479
Net Cash From Financing Activities
143 74 201 579 67 58 664 104 -113 -1,063 244
Net Cash From Continuing Financing Activities
143 74 201 579 67 58 664 104 -113 -1,063 244
Repayment of Debt
0.00 0.00 -84 -1.70 -1.07 0.00 0.00 -15 -146 -818 -102
Repurchase of Common Equity
- -3.19 -1.72 -0.09 0.00 0.00 -125 -59 0.00 -131 -308
Issuance of Debt
0.00 74 0.13 564 - 0.00 724 89 0.00 0.00 848
Issuance of Common Equity
0.30 3.15 287 160 69 58 66 68 47 52 69
Other Financing Activities, net
4.75 0.00 0.00 -143 -1.04 0.00 -0.46 20 -14 -165 -263
Cash Income Taxes Paid
1.17 2.46 5.21 10 29 17 17 20 31 24 33

Quarterly Cash Flow Statements for Nutanix

This table details how cash moves in and out of Nutanix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q3 2026
Period end date 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 4/30/2026
Net Change in Cash & Equivalents
33 73 99 67 -81 56 61 406 -200 -103 116
Net Cash From Operating Activities
74 58 145 186 96 245 162 187 219 220 208
Net Cash From Continuing Operating Activities
74 58 145 186 96 245 162 187 219 220 208
Net Income / (Loss) Continuing Operations
-71 -13 -16 33 -16 -126 30 24 63 39 72
Consolidated Net Income / (Loss)
-71 -13 -16 33 -16 -126 30 24 63 39 72
Depreciation Expense
20 17 18 18 19 18 18 18 18 18 17
Amortization Expense
11 11 11 11 11 7.86 0.39 -0.18 1.33 1.36 1.36
Non-Cash Adjustments To Reconcile Net Income
73 60 85 87 83 193 88 110 81 86 81
Changes in Operating Assets and Liabilities, net
42 -16 47 37 -0.63 152 25 34 55 75 36
Net Cash From Investing Activities
-30 -8.91 -42 -25 -107 703 -28 -301 -351 -226 -41
Net Cash From Continuing Investing Activities
-30 -8.91 -42 -25 -107 703 -28 -301 -351 -226 -41
Purchase of Property, Plant & Equipment
-22 -13 -13 -24 -18 -20 -9.83 -22 -15 -12 -10
Purchase of Investments
-202 -244 -278 -177 -285 -131 -110 -203 -448 -418 -207
Sale and/or Maturity of Investments
194 242 249 180 196 855 92 -76 113 204 177
Net Cash From Financing Activities
-11 24 -4.37 -95 -71 -893 -72 520 -68 -97 -51
Net Cash From Continuing Financing Activities
-11 24 -4.37 -95 -71 -893 -72 520 -68 -97 -51
Repurchase of Common Equity
- - -18 -42 -47 -25 -20 -170 -38 -50 -50
Issuance of Common Equity
0.37 23 14 1.37 36 0.91 28 0.27 39 0.41 32
Other Financing Activities, net
-12 0.42 -0.64 -54 -60 -51 -80 -60 -66 -47 -33
Cash Income Taxes Paid
5.39 9.20 8.13 6.03 6.77 2.71 9.30 11 6.27 6.99 6.16

Annual Balance Sheets for Nutanix

This table presents Nutanix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 7/31/2016 7/31/2017 7/31/2018 7/31/2019 7/31/2020 7/31/2021 7/31/2022 7/31/2023 7/31/2024 7/31/2025
Total Assets
399 738 1,600 1,786 1,769 2,277 2,366 2,527 2,144 3,283
Total Current Assets
330 580 1,263 1,275 1,094 1,562 1,658 1,862 1,481 2,589
Cash & Equivalents
99 138 306 397 319 286 403 513 655 770
Short-Term Investments
86 211 628 512 401 928 921 924 339 1,223
Accounts Receivable
111 179 258 245 243 181 125 157 230 338
Prepaid Expenses
16 28 37 75 63 57 94 147 97 105
Other Current Assets
18 24 34 46 69 111 115 120 160 153
Plant, Property, & Equipment, net
42 58 85 137 143 132 113 112 136 143
Total Noncurrent Assets
27 100 252 374 531 584 594 553 526 551
Goodwill
0.00 17 88 185 185 185 185 185 185 185
Intangible Assets
0.00 26 45 67 49 32 16 4.89 5.15 2.62
Other Noncurrent Operating Assets
27 57 119 122 297 366 393 363 336 363
Total Liabilities & Shareholders' Equity
399 738 1,600 1,786 1,769 2,277 2,366 2,527 2,144 3,283
Total Liabilities
465 521 1,273 1,599 2,044 3,290 3,166 3,234 2,872 3,978
Total Current Liabilities
213 311 458 599 760 928 1,161 1,136 1,244 1,414
Accounts Payable
52 74 66 74 54 47 45 30 45 82
Accrued Expenses
5.54 9.71 32 29 26 39 60 109 25 24
Current Deferred Revenue
131 170 276 397 535 636 721 824 955 1,054
Current Employee Benefit Liabilities
25 58 85 100 109 162 150 144 196 230
Other Current Liabilities
- - - 0.00 37 43 40 30 24 23
Total Noncurrent Liabilities
252 210 815 1,000 1,283 2,362 2,006 2,098 1,628 2,564
Long-Term Debt
73 0.00 430 459 490 1,056 1,156 1,218 570 1,344
Noncurrent Deferred Revenue
166 - - 513 - 677 725 771 918 1,059
Other Noncurrent Operating Liabilities
13 210 385 28 793 629 125 109 139 162
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-376 217 327 187 -275 -1,012 -801 -707 -728 -695
Total Preferred & Common Equity
-376 217 327 187 -275 -1,012 -801 -707 -728 -695
Total Common Equity
-376 217 327 187 -275 -1,012 -801 -707 -728 -695
Common Stock
66 948 1,356 1,836 2,245 2,615 3,584 3,931 4,119 4,200
Retained Earnings
-442 -731 -1,028 -1,649 -2,522 -3,627 -4,378 -4,633 -4,847 -4,896
Accumulated Other Comprehensive Income / (Loss)
-0.01 -0.11 -1.00 0.67 2.03 -0.01 -6.08 -5.17 0.15 0.70

Quarterly Balance Sheets for Nutanix

This table presents Nutanix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q2 2026 Q3 2026
Period end date 4/30/2022 1/31/2023 4/30/2023 10/31/2023 1/31/2024 4/30/2024 10/31/2025 1/31/2025 4/30/2025 1/31/2026 4/30/2026
Total Assets
2,356 2,371 2,396 2,571 2,730 2,775 3,324 2,989 3,097 3,277 3,419
Total Current Assets
1,676 1,692 1,729 1,918 2,080 2,139 2,639 2,335 2,411 2,466 2,612
Cash & Equivalents
387 407 440 612 679 598 780 1,072 873 603 719
Short-Term Investments
914 905 919 959 965 1,053 1,282 671 1,010 1,271 1,299
Accounts Receivable
180 155 135 134 189 225 336 327 270 261 252
Prepaid Expenses
86 116 122 87 109 114 99 112 111 184 196
Other Current Assets
109 109 114 126 139 148 142 153 147 147 146
Plant, Property, & Equipment, net
117 113 115 110 115 115 138 139 144 132 127
Total Noncurrent Assets
562 567 552 542 534 521 547 515 542 679 680
Goodwill
185 185 185 185 185 185 185 185 185 185 185
Intangible Assets
20 9.94 7.33 3.75 6.88 6.02 2.42 3.44 2.81 2.23 2.03
Other Noncurrent Operating Assets
357 372 359 354 342 330 359 326 354 492 493
Total Liabilities & Shareholders' Equity
2,356 2,371 2,396 2,571 2,730 2,775 3,324 2,989 3,097 3,277 3,419
Total Liabilities
3,078 3,154 3,185 3,213 3,341 3,394 3,993 3,797 3,808 4,108 4,144
Total Current Liabilities
1,136 1,112 1,133 1,100 1,163 1,184 1,400 1,318 1,282 1,491 1,470
Accounts Payable
53 44 34 36 40 40 88 46 50 96 84
Accrued Expenses
48 108 109 21 22 22 25 22 22 27 28
Current Deferred Revenue
722 787 806 878 894 924 1,081 1,024 1,009 1,119 1,155
Current Employee Benefit Liabilities
123 138 152 136 178 173 182 203 176 215 165
Other Current Liabilities
44 34 31 29 29 24 24 22 25 33 37
Total Noncurrent Liabilities
1,942 2,042 2,052 2,113 2,178 2,211 2,593 2,479 2,527 2,618 2,674
Long-Term Debt
1,146 1,187 1,207 1,239 1,250 1,272 1,345 1,341 1,343 1,346 1,347
Noncurrent Deferred Revenue
710 - 737 768 815 824 1,090 995 1,020 1,078 1,152
Other Noncurrent Operating Liabilities
86 855 108 106 113 115 158 143 163 194 175
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-722 -783 -789 -642 -612 -619 -669 -808 -711 -831 -726
Total Preferred & Common Equity
-722 -783 -789 -642 -612 -619 -669 -808 -711 -831 -726
Total Common Equity
-722 -783 -789 -642 -612 -619 -669 -808 -711 -831 -726
Common Stock
3,501 3,772 3,835 4,021 4,040 4,087 4,201 4,121 4,180 4,151 4,219
Retained Earnings
-4,217 -4,549 -4,620 -4,659 -4,652 -4,702 -4,873 -4,929 -4,894 -4,986 -4,945
Accumulated Other Comprehensive Income / (Loss)
-6.15 -5.80 -4.28 -4.38 0.88 -3.70 3.61 0.40 3.39 4.06 -0.31

Annual Metrics And Ratios for Nutanix

This table displays calculated financial ratios and metrics derived from Nutanix's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 7/31/2015 7/31/2016 7/31/2017 7/31/2018 7/31/2019 7/31/2020 7/31/2021 7/31/2022 7/31/2023 7/31/2024 7/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 108.51% 68.03% 36.59% 6.98% 5.79% 6.63% 13.37% 17.85% 15.35% 18.11%
EBITDA Growth
0.00% 26.37% -323.09% 33.19% -125.22% -44.26% -17.63% 24.14% 82.42% 111.77% 2,038.02%
EBIT Growth
0.00% 14.98% -253.85% 22.70% -111.61% -39.50% -18.93% 23.34% 70.04% 56.62% 308.89%
NOPAT Growth
0.00% 11.91% -233.00% 19.52% -113.28% -38.61% 20.12% 30.70% 54.85% 103.65% 2,800.60%
Net Income Growth
0.00% 14.19% -250.76% 21.73% -109.04% -40.52% -18.64% 22.85% 68.14% 50.98% 250.96%
EPS Growth
0.00% 20.90% -20.33% 38.85% -89.50% -30.61% -12.05% 27.89% 69.89% 53.21% 227.45%
Operating Cash Flow Growth
0.00% 114.15% 306.46% 526.16% -54.43% -479.16% 37.57% 167.67% 303.30% 147.04% 22.07%
Free Cash Flow Firm Growth
0.00% 0.00% -376.93% 48.11% -121.83% -1.56% 159.65% -430.66% 93.79% 657.07% 49.13%
Invested Capital Growth
0.00% 0.00% 25.80% -34.80% -47.83% -91.82% -131.91% 29.65% -12.58% -24.36% -16.58%
Revenue Q/Q Growth
0.00% 0.00% 6.84% 4.65% -0.31% 0.00% 0.00% -3.67% 9.64% 2.57% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% -27.74% -3.60% -23.38% -696.57% -676.93% -23.28% 79.97% -89.39% 0.00%
EBIT Q/Q Growth
0.00% 0.00% -25.47% -6.89% -20.42% 0.00% 0.00% -16.90% 66.34% -1,098.70% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% -28.13% -5.73% -20.88% 0.00% 0.00% -11.66% 46.46% 153.43% 0.00%
Net Income Q/Q Growth
0.00% 0.00% -25.22% -7.70% -20.80% 0.00% 0.00% -16.46% 64.33% -943.18% 0.00%
EPS Q/Q Growth
0.00% 0.00% -3.86% -57.39% -18.69% 0.00% 0.00% -14.92% 66.04% -920.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 43.92% 20.68% -43.44% 7.67% -39.50% 1,275.90% 8.05% 38.31% -2.97%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 48.94% -8.03% -235.46% -61.85% -28.46% 32.79% 374.39% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 48.26% -21.60% -43.02% -16.26% -21.43% -12.58% 1.45% -15.37% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.18% 66.07% 61.30% 66.59% 75.40% 78.08% 79.07% 79.68% 82.17% 84.92% 86.81%
EBITDA Margin
-44.73% -15.79% -39.77% -19.45% -40.94% -55.83% -61.60% -41.21% -6.15% 0.63% 11.36%
Operating Margin
-49.19% -20.78% -41.19% -24.27% -48.38% -63.39% -47.48% -29.03% -11.12% 0.35% 6.80%
EBIT Margin
-51.60% -21.04% -44.31% -25.07% -49.59% -65.40% -72.94% -49.32% -12.54% -4.72% 8.34%
Profit (Net Income) Margin
-52.24% -21.50% -44.88% -25.72% -50.25% -66.75% -74.27% -50.54% -13.66% -5.81% 7.42%
Tax Burden Percent
101.24% 102.19% 101.29% 102.57% 101.32% 102.07% 101.82% 102.47% 108.98% 123.15% 89.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 164.15% -502.41% -109.28% -241.86% 1,981.93% 160.93% 88.16% 33.76% 17.38% -26.48%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -26.54% -65.91% -24.78% -36.21% -48.12% -50.28% -33.58% -9.55% -4.34% 7.80%
Return on Assets (ROA)
0.00% -27.12% -66.76% -25.42% -36.69% -49.11% -51.19% -34.41% -10.41% -5.34% 6.94%
Return on Common Equity (ROCE)
0.00% 936.84% 529.42% -109.28% -241.86% 1,981.93% 160.93% 88.16% 33.76% 17.38% -26.48%
Return on Equity Simple (ROE_SIMPLE)
0.00% 28.76% -174.90% -90.94% -332.37% 317.44% 102.33% 99.81% 35.98% 17.14% 0.00%
Net Operating Profit after Tax (NOPAT)
-83 -73 -244 -196 -419 -580 -463 -321 -145 5.29 154
NOPAT Margin
-34.43% -14.55% -28.83% -16.99% -33.87% -44.37% -33.24% -20.32% -7.78% 0.25% 6.05%
Net Nonoperating Expense Percent (NNEP)
0.00% -62.52% -58.90% -23.63% -42.44% -86.14% -295.21% -528.91% -90.60% -40.43% 6.49%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 23.65%
Cost of Revenue to Revenue
41.82% 33.93% 38.70% 33.41% 24.60% 21.92% 20.93% 20.32% 17.83% 15.08% 13.19%
SG&A Expenses to Revenue
9.90% 6.81% 9.14% 7.48% 9.67% 10.37% 11.03% 10.53% 12.46% 9.35% 9.35%
R&D to Revenue
30.45% 23.12% 34.12% 27.16% 40.51% 42.36% 40.02% 36.25% 31.19% 29.74% 29.03%
Operating Expenses to Revenue
107.38% 86.86% 102.49% 90.86% 123.78% 141.47% 126.55% 108.71% 93.29% 84.56% 80.01%
Earnings before Interest and Taxes (EBIT)
-125 -106 -375 -290 -613 -855 -1,017 -780 -234 -101 212
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-108 -80 -336 -225 -506 -730 -859 -651 -115 13 288
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 14.83 25.54 22.59 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 18.46 43.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 3.81 7.22 3.41 3.39 5.47 2.15 3.82 5.80 7.94
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 106.98
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.93%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 3.39 6.79 3.05 3.21 5.35 2.13 3.70 5.60 7.68
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 892.63 67.66
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 92.15
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,273.01 127.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 194.21 84.72 89.44 0.00 0.00 49.91 25.33 17.88 23.74
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 36.93 0.00 0.00 52.08 56.60
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 -1.11 0.00 1.31 2.46 -1.78 -1.04 -1.63 -1.72 -0.78 -1.93
Long-Term Debt to Equity
0.00 -1.11 0.00 1.31 2.46 -1.78 -1.04 -1.44 -1.72 -0.78 -1.93
Financial Leverage
0.00 1.70 -3.05 -1.57 -1.86 7.71 0.30 0.10 0.16 0.45 0.75
Leverage Ratio
0.00 -6.05 7.53 4.30 6.59 -40.35 -3.14 -2.56 -3.24 -3.25 -3.81
Compound Leverage Factor
0.00 -6.05 7.53 4.30 6.59 -40.35 -3.14 -2.56 -3.24 -3.25 -3.81
Debt to Total Capital
0.00% 1,000.27% 0.00% 56.80% 71.06% 227.75% 2,418.38% 259.73% 238.51% -360.63% 206.96%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 29.02% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 1,000.27% 0.00% 56.80% 71.06% 227.75% 2,418.38% 230.71% 238.51% -360.63% 206.96%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 4,237.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -5,138.11% 100.00% 43.20% 28.94% -127.75% -2,318.38% -159.73% -138.51% 460.63% -106.96%
Debt to EBITDA
0.00 -0.92 0.00 -1.91 -0.91 -0.67 -1.23 -2.00 -10.63 42.29 4.66
Net Debt to EBITDA
0.00 1.41 0.00 2.25 0.89 0.31 0.18 0.03 1.91 -31.47 -2.25
Long-Term Debt to EBITDA
0.00 -0.92 0.00 -1.91 -0.91 -0.67 -1.23 -1.77 -10.63 42.29 4.66
Debt to NOPAT
0.00 -1.00 0.00 -2.19 -1.10 -0.84 -2.28 -4.05 -8.40 107.68 8.75
Net Debt to NOPAT
0.00 1.53 0.00 2.57 1.07 0.40 0.34 0.07 1.51 -80.14 -4.23
Long-Term Debt to NOPAT
0.00 -1.00 0.00 -2.19 -1.10 -0.84 -2.28 -3.60 -8.40 107.68 8.75
Altman Z-Score
0.00 0.00 2.23 3.76 0.30 -1.33 -1.37 -2.12 -0.47 0.42 2.37
Noncontrolling Interest Sharing Ratio
0.00% -470.73% 205.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 1.55 1.86 2.76 2.13 1.44 1.68 1.43 1.64 1.19 1.83
Quick Ratio
0.00 1.39 1.70 2.60 1.93 1.27 1.50 1.25 1.40 0.98 1.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 105 -290 -150 -334 -339 202 -668 -41 231 345
Operating Cash Flow to CapEx
-110.24% 8.60% 29.45% 148.37% 35.60% -178.67% -170.19% 137.68% 416.49% 894.24% 1,152.39%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 1.26 1.49 0.99 0.73 0.74 0.69 0.68 0.76 0.92 0.94
Accounts Receivable Turnover
0.00 4.55 5.84 5.29 4.91 5.36 6.59 10.35 13.22 11.10 8.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 11.92 16.87 16.14 11.13 9.34 10.15 12.90 16.54 17.33 18.19
Accounts Payable Turnover
0.00 3.28 5.20 5.55 4.36 4.48 5.78 6.98 8.88 8.64 5.29
Days Sales Outstanding (DSO)
0.00 80.23 62.47 69.05 74.37 68.10 55.40 35.25 27.61 32.87 40.83
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 111.37 70.16 65.82 83.74 81.53 63.20 52.27 41.13 42.23 69.05
Cash Conversion Cycle (CCC)
0.00 -31.14 -7.69 3.23 -9.37 -13.43 -7.80 -17.02 -13.52 -9.36 -28.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 -178 -132 -178 -263 -505 -1,170 -823 -927 -1,152 -1,343
Invested Capital Turnover
0.00 -5.66 -5.46 -7.46 -5.61 -3.41 -1.67 -1.59 -2.13 -2.07 -2.03
Increase / (Decrease) in Invested Capital
0.00 -178 46 -46 -85 -242 -666 347 -104 -226 -191
Enterprise Value (EV)
0.00 0.00 2,870 7,840 3,771 4,199 7,463 3,371 6,901 12,034 19,502
Market Capitalization
0.00 0.00 3,219 8,345 4,221 4,428 7,621 3,394 7,120 12,458 20,151
Book Value per Share
$0.00 ($8.56) $1.43 $1.91 $1.01 ($1.38) ($4.78) ($3.57) ($3.00) ($2.95) ($2.59)
Tangible Book Value per Share
$0.00 ($8.56) $1.15 $1.13 ($0.35) ($2.55) ($5.81) ($4.47) ($3.81) ($3.72) ($3.29)
Total Capital
0.00 7.32 217 756 646 215 44 501 511 -158 649
Total Debt
0.00 73 0.00 430 459 490 1,056 1,302 1,218 570 1,344
Total Long-Term Debt
0.00 73 0.00 430 459 490 1,056 1,156 1,218 570 1,344
Net Debt
0.00 -112 -349 -505 -450 -230 -158 -23 -219 -424 -649
Capital Expenditures (CapEx)
23 42 50 62 118 89 59 49 65 75 71
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -68 -80 -129 -233 -386 -579 -681 -712 -757 -817
Debt-free Net Working Capital (DFNWC)
0.00 117 269 805 676 334 634 643 726 237 1,176
Net Working Capital (NWC)
0.00 117 269 805 676 334 634 497 726 237 1,176
Net Nonoperating Expense (NNE)
43 35 136 101 203 293 572 478 110 130 -35
Net Nonoperating Obligations (NNO)
0.00 -112 -349 -505 -450 -230 -158 -23 -219 -424 -649
Total Depreciation and Amortization (D&A)
17 26 38 65 107 125 158 128 119 115 77
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -13.53% -9.46% -11.20% -18.84% -29.51% -41.55% -43.11% -38.21% -35.25% -32.20%
Debt-free Net Working Capital to Revenue
0.00% 23.26% 31.81% 69.66% 54.68% 25.53% 45.50% 40.67% 38.95% 11.03% 46.32%
Net Working Capital to Revenue
0.00% 23.26% 31.81% 69.66% 54.68% 25.53% 45.50% 31.47% 38.95% 11.03% 46.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($3.11) ($3.83) ($3.57) ($1.81) ($3.43) $0.00 ($5.01) ($3.62) ($1.09) ($0.51) $0.70
Adjusted Weighted Average Basic Shares Outstanding
40.51M 43.97M 154.94M 172.89M 188.86M 0.00 214.22M 220.53M 233.25M 244.74M 267.48M
Adjusted Diluted Earnings per Share
($3.11) ($3.83) ($3.57) ($1.81) ($3.43) $0.00 ($5.01) ($3.62) ($1.09) ($0.51) $0.65
Adjusted Weighted Average Diluted Shares Outstanding
40.51M 43.97M 154.94M 172.89M 188.86M 0.00 214.22M 220.53M 233.25M 244.74M 294.08M
Adjusted Basic & Diluted Earnings per Share
($3.11) ($3.83) ($3.57) ($1.81) ($3.43) $0.00 ($5.01) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
40.51M 43.97M 128.30M 164.09M 181.03M 0.00 206.48M 227.03M 239.61M 265.21M 268.80M
Normalized Net Operating Profit after Tax (NOPAT)
-83 -73 -244 -196 -419 -580 -463 -321 -145 5.29 154
Normalized NOPAT Margin
-34.43% -14.55% -28.83% -16.99% -33.87% -44.37% -33.24% -20.32% -7.78% 0.25% 6.05%
Pre Tax Income Margin
-51.60% -21.04% -44.31% -25.07% -49.59% -65.40% -72.94% -49.32% -12.54% -4.72% 8.34%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -2.94% -0.45% -0.03% 0.00% 0.00% -12.08% -7.33% 0.00% -105.10% 163.46%

Quarterly Metrics And Ratios for Nutanix

This table displays calculated financial ratios and metrics derived from Nutanix's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 1/31/2026 4/30/2026
DEI Shares Outstanding
- - - - - - - - - 270,399,924.00 265,212,097.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 270,399,924.00 265,212,097.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.38 0.27
Growth Metrics
- - - - - - - - - - -
Revenue Growth
28.19% 17.86% 16.18% 16.94% 10.87% 0.00% 15.83% 21.81% 19.22% - 10.03%
EBITDA Growth
118.46% 111.90% 288.56% 153.78% -538.41% 630.24% -5.11% 339.43% 170.02% - 18.91%
EBIT Growth
95.13% 88.33% 158.75% 83.39% -1,573.00% 435.33% 66.28% 691.08% 138.08% - 25.88%
NOPAT Growth
91.54% 92.93% 178.47% 80.24% -7.41% 654.45% 82.79% 688.22% 413.18% - 31.01%
Net Income Growth
91.24% 84.07% 146.33% 78.00% -849.06% 0.00% 72.06% 505.76% 130.65% - 13.77%
EPS Growth
93.75% 84.09% 138.71% 80.00% -1,150.00% 0.00% 58.33% 466.67% 128.00% - 13.64%
Operating Cash Flow Growth
53.43% 146.90% 151.62% 29.34% 319.66% 0.00% 0.00% 126.78% -10.29% - -5.04%
Free Cash Flow Firm Growth
121.68% 229.83% 5.75% -69.95% 127.27% -98.13% 102.12% 494.29% 0.23% - -30.95%
Invested Capital Growth
-12.58% 0.00% -10.79% -6.23% -24.36% 0.00% -20.29% -25.27% -16.58% - -11.57%
Revenue Q/Q Growth
10.17% 3.41% 10.60% -7.19% 4.46% 7.85% 0.00% -2.40% 2.24% - -2.73%
EBITDA Q/Q Growth
159.38% -64.04% 804.26% -72.14% -584.01% 159.90% 0.00% 29.00% -22.88% - 2.39%
EBIT Q/Q Growth
89.23% -54.97% 456.44% -127.92% -984.72% 131.06% 0.00% -0.74% -30.12% - -16.61%
NOPAT Q/Q Growth
80.65% 49.71% 877.10% -126.13% -5.18% 359.58% 0.00% -15.90% -44.00% - -29.69%
Net Income Q/Q Growth
81.28% -19.31% 306.87% -147.62% -707.51% 123.73% 0.00% 12.29% -39.00% - -30.03%
EPS Q/Q Growth
86.67% -75.00% 271.43% -150.00% -733.33% 120.00% 0.00% 15.79% -36.36% - -30.56%
Operating Cash Flow Q/Q Growth
-21.73% 177.40% 15.24% -48.31% 153.96% -33.90% 0.00% 0.00% 0.47% - 0.00%
Free Cash Flow Firm Q/Q Growth
-43.13% 1,141.10% -89.13% -60.84% 330.13% -89.81% 0.00% 15.15% -27.45% - -13.23%
Invested Capital Q/Q Growth
1.45% -28.45% 15.55% 0.63% -15.37% -3.29% 0.00% -3.49% -7.36% - -2.72%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
83.72% 83.96% 85.57% 84.82% 85.22% 86.01% 86.97% 87.01% 87.17% - 86.87%
EBITDA Margin
4.27% 1.48% 12.13% 3.64% -16.88% 9.37% 9.94% 13.14% 9.91% - 14.20%
Operating Margin
-2.30% -1.12% 6.55% -2.21% -2.22% 4.61% 9.99% 7.61% 4.78% - 10.03%
EBIT Margin
-1.43% -2.15% 6.92% -2.08% -21.63% 6.23% 9.94% 10.11% 6.91% - 11.57%
Profit (Net Income) Margin
-2.69% -3.10% 5.80% -2.98% -23.01% 5.06% 8.62% 9.92% 5.92% - 10.25%
Tax Burden Percent
187.51% 144.37% 83.79% 142.89% 106.37% 81.27% 86.70% 98.09% 85.62% - 88.65%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Effective Tax Rate
0.00% 0.00% 16.21% 0.00% 0.00% 18.73% 13.30% 1.91% 14.38% - 11.35%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)
33.76% 24.94% 9.66% 1.70% 17.38% 0.00% 0.00% 0.00% -26.48% - 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Return on Assets (OROA)
-1.09% -1.91% 5.48% -1.69% -19.91% 0.00% 0.00% 0.00% 6.46% - 0.00%
Return on Assets (ROA)
-2.05% -2.76% 4.59% -2.41% -21.17% 0.00% 0.00% 0.00% 5.53% - 0.00%
Return on Common Equity (ROCE)
33.76% 24.94% 9.66% 1.70% 17.38% 0.00% 0.00% 0.00% -26.48% - 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 24.94% 11.00% 1.93% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
-7.94 -3.99 31 -8.11 -8.53 22 57 48 27 89 63
NOPAT Margin
-1.61% -0.78% 5.49% -1.55% -1.56% 3.75% 8.67% 7.47% 4.09% - 8.89%
Net Nonoperating Expense Percent (NNEP)
-4.42% -4.70% 0.68% -2.83% -36.54% 1.54% -0.08% 3.40% 2.22% - 1.58%
Return On Investment Capital (ROIC_SIMPLE)
- 3.48% 4.86% - - -19.28% 10.63% 7.56% 4.12% 17.26% 10.05%
Cost of Revenue to Revenue
16.28% 16.04% 14.43% 15.18% 14.78% 13.99% 13.03% 12.99% 12.83% - 13.13%
SG&A Expenses to Revenue
10.01% 9.30% 8.76% 9.80% 9.56% 9.08% 9.14% 9.47% 9.69% - 8.62%
R&D to Revenue
29.58% 29.74% 28.38% 30.35% 30.55% 29.44% 27.92% 29.17% 29.65% - 27.89%
Operating Expenses to Revenue
86.02% 85.08% 79.02% 87.03% 87.45% 81.40% 76.98% 79.40% 82.39% - 76.85%
Earnings before Interest and Taxes (EBIT)
-7.09 -11 39 -11 -119 37 65 65 45 98 81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
21 7.59 69 19 -92 55 65 84 65 98 100
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)
3.82 4.47 6.76 7.08 5.80 0.00 0.00 0.00 7.94 - 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 106.98 - 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.93% - 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Revenue (EV/Rev)
3.70 4.21 6.56 6.90 5.60 0.00 0.00 0.00 7.68 - 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 182.91 113.75 892.63 0.00 0.00 0.00 67.66 - 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 1,424.48 0.00 0.00 0.00 0.00 92.15 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 2,273.01 0.00 0.00 0.00 127.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
25.33 23.18 28.50 29.70 17.88 0.00 24.88 21.00 23.74 - 12.39
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 7.44 186.89 296.70 52.08 0.00 0.00 0.00 56.60 - 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-1.72 -0.83 -2.04 -2.05 -0.78 -0.83 -1.66 -1.89 -1.93 - -1.86
Long-Term Debt to Equity
-1.72 -0.83 -2.04 -2.05 -0.78 -0.83 -1.66 -1.89 -1.93 - -1.86
Financial Leverage
0.16 0.74 0.37 0.38 0.45 0.76 0.56 0.69 0.75 - 0.84
Leverage Ratio
-3.24 -3.18 -3.66 -3.67 -3.25 -3.58 -4.03 -4.41 -3.81 - -4.53
Compound Leverage Factor
-3.24 -3.18 -3.66 -3.67 -3.25 -3.58 -4.03 -4.41 -3.81 - -4.53
Debt to Total Capital
238.51% -496.75% 195.76% 194.94% -360.63% -496.75% 251.33% 212.72% 206.96% - 216.68%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital
238.51% -496.75% 195.76% 194.94% -360.63% -496.75% 251.33% 212.72% 206.96% - 216.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
-138.51% 596.75% -95.76% -94.94% 460.63% 596.75% -151.33% -112.72% -106.96% - -116.68%
Debt to EBITDA
-10.63 -17.53 17.27 10.01 42.29 0.00 0.00 0.00 4.66 - 0.00
Net Debt to EBITDA
1.91 15.52 -5.43 -2.99 -31.47 0.00 0.00 0.00 -2.25 - 0.00
Long-Term Debt to EBITDA
-10.63 -17.53 17.27 10.01 42.29 0.00 0.00 0.00 4.66 - 0.00
Debt to NOPAT
-8.40 -6.16 -46.22 -128.37 107.68 0.00 0.00 0.00 8.75 - 0.00
Net Debt to NOPAT
1.51 5.46 14.55 38.29 -80.14 0.00 0.00 0.00 -4.23 - 0.00
Long-Term Debt to NOPAT
-8.40 -6.16 -46.22 -128.37 107.68 0.00 0.00 0.00 8.75 - 0.00
Altman Z-Score
-0.17 -0.25 1.25 1.40 0.39 0.57 0.00 0.00 2.20 - 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.64 1.25 1.79 1.81 1.19 1.25 1.77 1.88 1.83 - 1.78
Quick Ratio
1.40 1.04 1.58 1.59 0.98 1.04 1.57 1.68 1.65 - 1.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
96 1,186 129 51 217 22 261 300 218 239 207
Operating Cash Flow to CapEx
455.50% 1,645.32% 784.41% 534.43% 1,197.21% 1,645.32% 0.00% 1,447.54% 1,868.33% - 2,010.11%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.76 0.89 0.79 0.81 0.92 0.00 0.00 0.00 0.94 - 0.00
Accounts Receivable Turnover
13.22 9.77 11.73 11.63 11.10 0.00 0.00 0.00 8.94 - 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover
16.54 14.65 17.73 18.20 17.33 0.00 0.00 0.00 18.19 - 0.00
Accounts Payable Turnover
8.88 7.42 7.81 8.68 8.64 0.00 0.00 0.00 5.29 - 0.00
Days Sales Outstanding (DSO)
27.61 37.36 31.12 31.39 32.87 0.00 0.00 0.00 40.83 - 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)
41.13 49.19 46.75 42.03 42.23 0.00 0.00 0.00 69.05 - 0.00
Cash Conversion Cycle (CCC)
-13.52 -11.84 -15.63 -10.64 -9.36 0.00 0.00 0.00 -28.22 - 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-927 -1,190 -1,005 -999 -1,152 -1,190 -1,209 -1,251 -1,343 -1,359 -1,396
Invested Capital Turnover
-2.13 -3.26 -2.11 -2.16 -2.07 0.00 0.00 0.00 -2.03 - 0.00
Increase / (Decrease) in Invested Capital
-104 -1,190 -98 -59 -226 0.00 -204 -252 -191 -150 -145
Enterprise Value (EV)
6,901 8,167 13,246 14,451 12,034 15,965 18,023 17,780 19,502 - 10,174
Market Capitalization
7,120 8,672 13,639 14,831 12,458 16,470 18,424 18,320 20,151 - 10,845
Book Value per Share
($3.00) ($2.86) ($2.52) ($2.54) ($2.95) ($2.58) ($3.01) ($2.67) ($2.59) ($3.07) ($2.74)
Tangible Book Value per Share
($3.81) ($3.65) ($3.31) ($3.32) ($3.72) ($3.30) ($3.72) ($3.37) ($3.29) ($3.77) ($3.44)
Total Capital
511 -115 639 653 -158 -115 534 631 649 515 622
Total Debt
1,218 570 1,250 1,272 570 570 1,341 1,343 1,344 1,346 1,347
Total Long-Term Debt
1,218 570 1,250 1,272 570 570 1,341 1,343 1,344 1,346 1,347
Net Debt
-219 -505 -394 -379 -424 -505 -401 -540 -649 -528 -670
Capital Expenditures (CapEx)
13 9.83 24 18 20 9.83 0.00 15 12 0.00 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-712 -773 -726 -696 -757 -773 -725 -753 -817 -898 -876
Debt-free Net Working Capital (DFNWC)
726 303 918 956 237 303 1,018 1,129 1,176 976 1,142
Net Working Capital (NWC)
726 303 918 956 237 303 1,018 1,129 1,176 976 1,142
Net Nonoperating Expense (NNE)
5.34 12 -1.76 7.50 118 -7.78 0.31 -16 -12 -14 -9.58
Net Nonoperating Obligations (NNO)
-219 -505 -394 -379 -424 -505 -401 -540 -649 -528 -670
Total Depreciation and Amortization (D&A)
28 19 29 30 26 19 0.00 19 20 0.00 19
Debt-free, Cash-free Net Working Capital to Revenue
-38.21% -39.82% -35.97% -33.21% -35.25% 0.00% 0.00% 0.00% -32.20% - 0.00%
Debt-free Net Working Capital to Revenue
38.95% 15.61% 45.45% 45.62% 11.03% 0.00% 0.00% 0.00% 46.32% - 0.00%
Net Working Capital to Revenue
38.95% 15.61% 45.45% 45.62% 11.03% 0.00% 0.00% 0.00% 46.32% - 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.04) ($0.07) $0.13 ($0.06) ($0.51) $0.11 $0.21 $0.24 $0.14 $0.38 $0.27
Adjusted Weighted Average Basic Shares Outstanding
233.25M 241.49M 243.85M 245.77M 244.74M 266.56M 267.14M 267.57M 267.48M 268.28M 265.95M
Adjusted Diluted Earnings per Share
($0.04) ($0.07) $0.12 ($0.06) ($0.50) $0.10 $0.19 $0.22 $0.14 $0.36 $0.25
Adjusted Weighted Average Diluted Shares Outstanding
233.25M 241.49M 298.54M 245.77M 244.74M 288.83M 293.35M 296.80M 294.08M 291.91M 287.48M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
239.61M 267.93M 244.33M 246.64M 265.21M 267.93M 266.66M 268.08M 268.80M 265.21M 270.32M
Normalized Net Operating Profit after Tax (NOPAT)
-7.94 -3.99 31 -8.11 -8.53 22 57 48 27 59 63
Normalized NOPAT Margin
-1.61% -0.78% 5.49% -1.55% -1.56% 3.75% 8.67% 7.47% 4.09% - 8.89%
Pre Tax Income Margin
-1.43% -2.15% 6.92% -2.08% -21.63% 6.23% 9.94% 10.11% 6.91% - 11.57%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
0.00% -10.25% -87.93% -887.31% -105.10% 0.00% 0.00% 0.00% 163.46% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Nutanix (NASDAQ: NTNX) showed a meaningful improvement in profitability and cash generation over the last several years, with the most recent quarter continuing that trend. Revenue grew year over year, operating income stayed positive, and operating cash flow remained solid. At the same time, the company still carries a large debt load and negative shareholders’ equity, so the balance sheet is improved but not yet fully clean.

  • Revenue continues to rise: Q3 2026 revenue was $703.1 million, up from $639.0 million in Q3 2025 and $548.0 million in Q4 2025.
  • Gross profit expanded to $610.8 million in Q3 2026, showing Nutanix still converts most revenue into gross profit.
  • Operating income improved to $70.5 million in Q3 2026, versus $48.6 million in Q3 2025 and just $31.2 million in Q4 2025.
  • Net income remained positive at $72.1 million in Q3 2026, above $63.4 million in Q3 2025.
  • Operating cash flow stayed strong at $207.5 million in Q3 2026, one of the clearest signs of improving business quality.
  • The company ended Q3 2026 with $2.02 billion in cash and short-term investments, giving it substantial liquidity.
  • Total current assets of $2.61 billion continue to provide a solid cushion against near-term obligations.
  • Deferred revenue remains large, with $1.15 billion current and $1.15 billion noncurrent, which supports future revenue recognition.
  • Share dilution appears modest in the latest quarter, with diluted shares at 287.5 million versus basic shares of 266.0 million.
  • Product investment remains high, with Q3 2026 R&D spending at $196.1 million and marketing at $283.6 million.
  • Total liabilities were $4.14 billion in Q3 2026, still high relative to the asset base.
  • Long-term debt remains elevated at $1.35 billion.
  • Shareholders’ equity was still negative at $(725.6) million, reflecting a leveraged balance sheet.
  • The company has continued to spend heavily on share repurchases, including $50.1 million in Q3 2026, which uses cash that could otherwise strengthen the balance sheet.

Looking at the broader trend, Nutanix has made a notable turnaround from the weaker 2022–2024 period, when the company was posting losses and weaker operating cash flow. In fiscal 2025 and into 2026, revenue growth accelerated, operating losses turned into operating profits, and cash generation improved materially. That said, investors should still watch the debt load and negative equity closely, because those are the main risks if growth slows or margins compress.

Bottom line: Nutanix currently looks like a company with improving fundamentals and strong cash generation, but the balance sheet is still a work in progress. For retail investors, the story is increasingly about execution on profitable growth rather than survival.

06/07/26 03:08 AM ETAI Generated. May Contain Errors.

Nutanix Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nutanix's financial year ends in July. Their financial year 2025 ended on July 31, 2025.

Over the last 10 years, Nutanix's net income changed from -$126.13 million in 2015 to $188.37 million in 2025, a change of -249.3%. Find out what analysts predict for Nutanix in the coming months.

Nutanix's total operating income in 2025 was $172.54 million, based on the following breakdown:
  • Total Gross Profit: $2.20 billion
  • Total Operating Expenses: $2.03 billion

Over the last 10 years, Nutanix's total revenue changed from $241.43 million in 2015 to $2.54 billion in 2025, a change of 951.2%.

Nutanix's total liabilities were at $3.98 billion at the end of 2025, a 38.5% increase from 2024, and a 755.4% increase since 2016.

In the past 9 years, Nutanix's cash and equivalents has ranged from $99.21 million in 2016 to $769.50 million in 2025, and is currently $769.50 million as of their latest financial filing in 2025.

Over the last 10 years, Nutanix's book value per share changed from 0.00 in 2015 to -2.59 in 2025, a change of -259.1%.



Financial statements for NASDAQ:NTNX last updated on 6/1/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners